Page last updated: 2024-12-06

triethyl phosphite

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Triethyl phosphite is a colorless liquid with a pungent odor, commonly used as a reagent in organic synthesis. It is synthesized by the reaction of phosphorus trichloride with ethanol in the presence of a base. Triethyl phosphite is known to undergo a variety of reactions, including the Arbuzov reaction, which is used to synthesize phosphonates. It is also employed in the preparation of other organophosphorus compounds, such as phosphites and phosphines. Triethyl phosphite serves as a versatile reducing agent and has been studied for its potential applications in various fields, including pharmaceuticals, agrochemicals, and materials science. Its reactivity and ability to participate in diverse reactions make it a valuable tool in chemical research and development. '

triethyl phosphite: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID31215
CHEMBL ID3186349
SCHEMBL ID6102
SCHEMBL ID6509618
MeSH IDM0070443

Synonyms (60)

Synonym
triethyl phosphite
ethyl phosphite, (eto)3p
nsc-5284
phosphorous acid, triethyl ester
nsc5284
triethoxyphosphine
122-52-1
einecs 204-552-5
hsdb 895
nsc 5284
brn 0956578
un2323
ai3-15624
fosforyn trojetylowy [czech]
inchi=1/c6h15o3p/c1-4-7-10(8-5-2)9-6-3/h4-6h2,1-3h
triethyl phosphite, 98%
NCGC00164018-01
FT-0653260
T0430
phosphorous acid triethyl ester
AKOS000119964
A804911
NCGC00164018-02
unii-6b2r04s55g
fosforyn trojetylowy
4-01-00-01333 (beilstein handbook reference)
ec 204-552-5
triethyl phosphite [un2323] [flammable liquid]
6b2r04s55g ,
triethylphosphite
cas-122-52-1
NCGC00257080-01
tox21_303083
dtxsid2026991 ,
dtxcid506991
NCGC00259152-01
tox21_201603
triethyl phosphite [hsdb]
triethyl phosphite [mi]
tris(ethoxy)phosphine
SCHEMBL6102
triethyl-phosphite
tri ethyl phosphite
p(oet)3
(c2h5o)3p
(eto)3p
p(oc2h5)3
SCHEMBL6509618
phosphorus ether
un 2323
CHEMBL3186349
mfcd00009084
J-525076
triethyl phosphite, purum, >=95.0% (gc)
Q414714
triethyl phosphite 100 microg/ml in acetonitrile
ethyl phosphite, (eto)3p (7ci); ethyl phosphite, et3po3 (4ci); nsc 5284; triethoxyphosphine; tris(ethoxy)phosphine
A937097
triethoxyphosphine-d15
BP-31214

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"The studies on toxic properties of trimethyl and triethyl phosphities involved: determination of acute general toxic effect on white rats following intragastric and intraperitoneal administration of these compounds, based on DL50 test, determination of damaging effect direction, by histopathological examination of animals' internal organs, determination of intensity of primarily irritating action on the skin, eye and conjunctiva, as well as sensitizing effect on guinea-pigs."( [Acute toxic effects of trimethyl and triethyl phosphites].
Czajkowska, T; Graczyk, J; Krysiak, B; Stetkiewicz, J, 1978
)
0.53
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency28.25760.002541.796015,848.9004AID1347395
retinoid X nuclear receptor alphaHomo sapiens (human)Potency22.26100.000817.505159.3239AID1159527
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency24.97730.023723.228263.5986AID743222
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency0.68590.000323.4451159.6830AID743065
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency62.18890.000627.21521,122.0200AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.69)18.7374
1990's1 (7.69)18.2507
2000's6 (46.15)29.6817
2010's4 (30.77)24.3611
2020's1 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 53.14

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index53.14 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index5.12 (4.65)
Search Engine Demand Index79.54 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (53.14)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]